While at MIT, ARMON SHAREI developed a relatively simple method to disrupt cell membranes enough to allow large molecules like proteins to quickly slip inside cells. Sharei, now 30, co-founded SQZ Biotech to sell the cell-squeezing tool to academic researchers. He joined the company as CEO in 2015 when it switched its focus to developing cell therapies for cancer and other diseases. Read Xconomy’s profile of Sharei.
Armon Sharei, SQZ Biotech • Photography by Alex Gagne and Rythum Vinoben